托西利祖马布在风炎和与巨细胞动脉炎相关的动脉瘤中的有效性
Adrián Martín-Gutiérrez1, Javier Loricera1, Javier Narváez2
1Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
托西利祖马布 (TCZ) 改善了巨细胞动脉炎与主动脉炎的临床和分析标志物. 然而,临床缓解并不总是与成像缓解一致,TCZ也没有阻止动脉瘤的进展.
科学领域:
- 类风湿病学 类风湿病学
- 血管炎症 血管炎症
- 免疫调节疗法是一种免疫调节疗法.
背景情况:
- 巨细胞动脉炎 (GCA) 经常涉及到主动脉 (GCA-主动脉炎),可能导致动脉瘤.
- 托西利祖马布 (TCZ) 已被批准用于GCA,但其在GCA-aortitis中的特定疗效及其对动脉瘤的影响仍未得到充分研究.
研究的目的:
- 评估TCZ在被诊断为GCA-aortitis的大群患者中的有效性和安全性.
- 评估TCZ对这一患者群体动脉瘤发育和进展的影响.
主要方法:
- 一项多中心的观察性研究包括196名用TCZ治疗的GCA-aortitis患者.
- 用既定标准和PET/CT成像证实了GCA和大炎的诊断.
- 主要结局包括EULAR和成像缓解,以及临床缓解,炎症标志物正常化和皮质类固醇缓解效应.
主要成果:
- 24个月后,81.4%的患者实现了EULAR缓解,31.8%的患者实现了成像缓解.
- 炎症标志物 (ESR,CRP) 的快速正常化和临床缓解在24个月后观察到高比例的患者.
- 虽然没有新的动脉瘤发展,但5个现有的动脉瘤需要手术,3个在TCZ治疗期间扩大.
结论:
- TCZ在GCA-aortitis中表现出快速和持续的临床和分析改善.
- 在接受TCZ治疗的患者中,临床/EULAR缓解和成像缓解之间存在显著的差异.
- 在GCA-aortitis中预防动脉瘤进展中的TCZ作用需要进一步研究.
更多相关视频
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
